Triple-negative breast cancer (TNBC) is a particularly aggressive subtype of breast cancer characterized by the absence of estrogen receptors, progesterone receptors, and overexpression of human epidermal growth factor receptor 2 (HER2) limiting treatment options. Here, ERBB2 is linked to triple-negative breast carcinoma.